Altamira Therapeutics Ltd. – Filings and Transcripts – BamSEC

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

SEC EDGAR

Financials Filter

ended 12/31/23 FY 2023 – amended

ended 12/31/23 FY 2023 – amended

ended 12/31/23 FY 2023

ended 12/31/22 FY 2022

Late filing notification for annual report of foreign issuer

Prospectuses and Registrations Filter

Prospectus supplement with pricing info

Initial registration of new securities for foreign issuers – amended

Initial registration of new securities for foreign issuers – amended

Initial registration of new securities for foreign issuers

Updated info for already-effective prospectus

Ownership Filter

Armistice Capital, LLC

News Filter

Announces Transition From NASDAQ to OTC Markets

Provides Update on Nasdaq Listing

Unaudited Condensed Consolidated Interim Financial Statements as of June 30, 2024 and for the Six Months Ended June 30, 2024 and 2023

Announces Pricing of Up to $12.0 Million Public Offering

Incorporation by Reference

Proxies

No filings in this category.

Other Filter

Notice of effectiveness

Correspondence with the SEC

Correspondence with the SEC

Letter from the SEC

Notice of effectiveness